Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted September 2, 2016
Kratom To Be Classified a Schedule I Controlled Substance
Kratom (Mitragyna speciosa), also called mitragynine extract, biak-biak, cratom, gratom, ithang, kakuam, katawn, kedemba, ketum, krathom, krton, mambog, madat, Maeng da leaf, nauclea, Nauclea speciosa, or thang is a tree native to Southeast Asia. Supplements containing kratom typically contain powdered leaves or extract sold in powder, capsules or liquid, and are promoted for pain relief or energy.
The active compounds in kratom are opioids which can have effects similar to morphine and heroin. Consumption of kratom has been associated with agitation, irritability, tachycardia, nausea, drowsiness, and hypertension. Health risks found in kratom abusers include hepatotoxicity, psychosis, seizure, weight loss, insomnia, tachycardia, vomiting, poor concentration, hallucinations, and death. The agency stated it is aware of 15 kratom-related deaths between 2014 and 2016.
Other Schedule I controlled substances include heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
U.S. Marshals have seized hundreds of thousands of dollars' worth of kratom supplements since that the FDA issued an import alert on all products containing kratom in 2014.
See Related Warnings:
To read the DEA's press release, use the link below.